Logo for Nanobiosym

Meet an Unreasonable Venture


Using nanotechnology to empower people worldwide with rapid, affordable, and portable diagnostic information about their own health.

Photo of Anita Goel

Anita Goel

Founder, Chairman, CEO at Nanobiosym

More about Anita »
Employees 21–50
Headquarters Cambridge, Massachusetts, United States
Nanobiosym Diagnostics has built and is now commercializing its FDA-authorized platform for Personalized Precision Medicine called Gene-RADAR. Harnessing more than 20 years of award-winning science and technology at the convergence of physics, nanotechnology, ICT, and biomedicine, Nanobiosym Dx is working to decentralize, democratize, mobilize, and personalize the next generation of healthcare delivery. The company aims to empower 8 billion consumers with real-time personalized mobile diagnostics and exponentially increase access to accurate diagnostics for anyone, anywhere and at any time. This includes the 4 billion people people globally who currently lack access to information about their health. Nanobiosym is part research institute and part incubator, advancing the frontiers of nanobiophysics and harnessing these innovations with novel business models and public-private partnerships to address our planet’s greatest unmet needs.

Press Mentions

November 1, 2020

Entrepreneurship As A Force For Good

Read on The Atlantic »

May 27, 2020

Precision Mobile Testing Is Key to Opening the Economy Safely

Read on Scientific American Blog Network »

More Ventures in Health

Get the Unreasonable Newsletter

Get twice-monthly updates on Nanobiosym and over 372 other ventures working to solve the world's toughest problems.

Read our Privacy Policy.